Overview
Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee
Status:
Terminated
Terminated
Trial end date:
2009-07-01
2009-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The primary aim of this study is to investigate if AZD1386 is efficacious as an analgesic in patients with osteoarthritis of the knee and at what dose. This will be done by comparing the effect of AZD1386 to placebo ("inactive substance") on pain.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AstraZeneca
Criteria
Inclusion Criteria:- Patients with OA of the knee
- Male or non pregnant females 40 and 80 years old
Exclusion Criteria:
- A current diagnosis of another form of arthritis, in addition to OA
- History, and/or presence of somatic disease, which may interfere with the objectives